OTCMKTS:IVOB - Invo Bioscience Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.4290 -0.01 (-2.50 %) (As of 03/20/2019 08:00 AM ET)Previous Close$0.44Today's Range$0.42 - $0.4452-Week Range$0.2501 - $0.77Volume5,400 shsAverage Volume30,073 shsMarket Capitalization$66.69 millionP/E RatioN/ADividend YieldN/ABeta-0.6 ProfileDiscussionChartEarningsInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email INVO Bioscience, Inc. provides solutions in assisted reproductive technologies to the reproductive health care community in the United States, Asia, South America, Central America, Europe, the Middle East, India and Africa. The company offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development. It also offers INVOcell Retention Device, a single-use, modified diaphragm that includes holes to allow for natural drainage of vaginal fluids; and INVO Holding/Warming Blocks that acts as a tool for viewing and retrieving the embryos from the inner chamber. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors. INVO Bioscience, Inc. is based in Medford, Massachusetts. Receive IVOB News and Ratings via Email Sign-up to receive the latest news and ratings for IVOB and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:IVOB Previous Symbol CUSIPN/A CIKN/A Webwww.invobioscience.com Phone978-878-9505Debt Debt-to-Equity RatioN/A Current Ratio0.17 Quick Ratio0.16Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$280,000.00 Price / Sales238.19 Cash FlowN/A Price / Cash FlowN/A Book Value($0.04) per share Price / Book-10.73Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-700,000.00 Net Margins-500.71% Return on EquityN/A Return on Assets-87.97%Miscellaneous EmployeesN/A Outstanding Shares155,460,000Market Cap$66.69 million Next Earnings Date4/4/2019 (Estimated) OptionableNot Optionable Invo Bioscience (OTCMKTS:IVOB) Frequently Asked Questions What is Invo Bioscience's stock symbol? Invo Bioscience trades on the OTCMKTS under the ticker symbol "IVOB." How were Invo Bioscience's earnings last quarter? Invo Bioscience Inc (OTCMKTS:IVOB) released its quarterly earnings data on Tuesday, August, 14th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.11 million for the quarter. View Invo Bioscience's Earnings History. When is Invo Bioscience's next earnings date? Invo Bioscience is scheduled to release their next quarterly earnings announcement on Thursday, April 4th 2019. View Earnings Estimates for Invo Bioscience. Has Invo Bioscience been receiving favorable news coverage? News coverage about IVOB stock has trended neutral recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Invo Bioscience earned a news impact score of 0.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days. Who are some of Invo Bioscience's key competitors? Some companies that are related to Invo Bioscience include SeaSpine (SPNE), Apyx Medical (APYX), Cytosorbents (CTSO), Nuvectra (NVTR), RenovaCare (RCAR), Sensus Healthcare (SRTS), Alphatec (ATEC), T2 Biosystems (TTOO), STRATA Skin Sciences (SSKN), iCAD (ICAD), Endologix (ELGX), Apollo Endosurgery (APEN), CAS Medical Systems (CASM), Titan Medical (TMDI) and Spectral Medical (EDTXF). What other stocks do shareholders of Invo Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other Invo Bioscience investors own include United States Brent Oil Fund (BNO), POET Technologies (POETF), National Bank of Canada (NA), Velocity Data (VCT), AAR (AIR), Lendlease Group (LLC), TrovaGene (TROV), Constellation Brands (STZ), Mid-America Apartment Communities (MAA) and Alibaba Group (BABA). Who are Invo Bioscience's key executives? Invo Bioscience's management team includes the folowing people: Ms. Kathleen T. Karloff, Chairman, CEO & Pres (Age 64)Mr. Robert Joseph Bowdring Jr., Acting CFO, Acting Principal Accounting Officer, Treasurer, Sec., Consultant & Director (Age 61)Dr. Kevin Doody, Medical Director & Director (Age 58) How do I buy shares of Invo Bioscience? Shares of IVOB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Invo Bioscience's stock price today? One share of IVOB stock can currently be purchased for approximately $0.4290. How big of a company is Invo Bioscience? Invo Bioscience has a market capitalization of $66.69 million and generates $280,000.00 in revenue each year. What is Invo Bioscience's official website? The official website for Invo Bioscience is http://www.invobioscience.com. How can I contact Invo Bioscience? Invo Bioscience's mailing address is 407R MYSTIC AVENUE SUITE 34C, MEDFORD MA, 02155. The company can be reached via phone at 978-878-9505 or via email at [email protected] MarketBeat Community Rating for Invo Bioscience (OTCMKTS IVOB)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 80 (Vote Outperform)Underperform Votes: 65 (Vote Underperform)Total Votes: 145MarketBeat's community ratings are surveys of what our community members think about Invo Bioscience and other stocks. Vote "Outperform" if you believe IVOB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVOB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/20/2019 by MarketBeat.com StaffFeatured Article: How Do Front-End Loads Impact an Investment?